Literature DB >> 9412580

Allergens of Aspergillus fumigatus and Candida boidinii share IgE-binding epitopes.

S Hemmann1, K Blaser, R Crameri.   

Abstract

From an Aspergillus fumigatus complementary deoxyribonucleic acid (cDNA) library displayed on phage surface, an allergen formally termed rAsp f 3 was cloned. The open-reading frame of the cloned gene for the allergen encodes a protein of 168 amino acids with a predicted molecular mass of 18.5 kD, showing 36% identity and 58% similarity to two peroxisomal membrane proteins of Candida boidinii. Recombinant Asp f 3 was expressed as a [His]6-tagged fusion protein in Escherichia coil at yields of 30 mg/L, and was purified by Ni(2+)-chelate chromatography. In an enzyme-linked immunosorbent assay (ELISA), serum IgE antibody reactivity to rAsp f 3 could be detected in 72% of 89 individuals sensitized to A. fumigatus, demonstrating that the protein represents a major allergen of the mold. IgE specific to rAsp f 3 and the two recombinant Candida proteins was further demonstrated by IgE-immunoblot analysis. IgE binding to rAsp f 3 could be inhibited in the ELISA by adding either of the recombinant Candida peroxisomal proteins to sera containing IgE directed against Asp f 3. Taken together, these observations prove that the Asperigillus allergen and the two Candida proteins share IgE-binding epitopes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9412580     DOI: 10.1164/ajrccm.156.6.9702087

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  17 in total

1.  Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis.

Authors:  James I Ito; Joseph M Lyons; Teresa B Hong; Daniel Tamae; Yi-Kuang Liu; Sharon P Wilczynski; Markus Kalkum
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

Review 2.  Structural aspects of fungal allergens.

Authors:  Reto Crameri
Journal:  Semin Immunopathol       Date:  2014-11-21       Impact factor: 9.623

3.  Cell specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis.

Authors:  V L Kinnula; S Lehtonen; R Kaarteenaho-Wiik; E Lakari; P Pääkkö; S W Kang; S G Rhee; Y Soini
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

4.  Fungal antigens expressed during invasive aspergillosis.

Authors:  Nicole Denikus; Foteini Orfaniotou; Gerald Wulf; Paul F Lehmann; Michel Monod; Utz Reichard
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Development of a Dot-Blot Assay for the Detection of Mould-Specific IgE in the Belgian Population.

Authors:  Muriel Vincent; Marta Romano; Francis Corazza; Kris Huygen; Olivier Michel; Olivier Denis
Journal:  Mycopathologia       Date:  2016-11-22       Impact factor: 2.574

6.  Identification and expression of an allergen Asp f 13 from Aspergillus fumigatus and epitope mapping using human IgE antibodies and rabbit polyclonal antibodies.

Authors:  L P Chow; S L Liu; C J Yu; H K Liao; J J Tsai; T K Tang
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

Review 7.  Animal models of allergic bronchopulmonary aspergillosis.

Authors:  Viswanath P Kurup; Gabriele Grunig
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

Review 8.  Assessment and control of fungal allergens.

Authors:  L Dziadzio; R K Bush
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

9.  Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate.

Authors:  Kris I Orsborn; Lisa F Shubitz; Tao Peng; Ellen M Kellner; Marc J Orbach; Paul A Haynes; John N Galgiani
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

10.  Immunological characterization of Asp f 2, a major allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis.

Authors:  B Banerjee; P A Greenberger; J N Fink; V P Kurup
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.